These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 32404537)
1. Circulating MicroRNA-423-3p Improves the Prediction of Coronary Artery Disease in a General Population - Six-Year Follow-up Results From the China-Cardiovascular Disease Study. Wang X; Dong Y; Fang T; Wang X; Chen L; Zheng C; Kang Y; Jiang L; You X; Gai S; Wang Z; Cao H Circ J; 2020 Jun; 84(7):1155-1162. PubMed ID: 32404537 [TBL] [Abstract][Full Text] [Related]
2. Identification of plasma miR-4505, miR-4743-5p and miR-4750-3p as novel diagnostic biomarkers for coronary artery disease in patients with type 2 diabetes mellitus: a case-control study. Szydełko J; Czop M; Petniak A; Lenart-Lipińska M; Kocki J; Zapolski T; Matyjaszek-Matuszek B Cardiovasc Diabetol; 2024 Jul; 23(1):278. PubMed ID: 39080630 [TBL] [Abstract][Full Text] [Related]
3. MiR-223-3p and miR-122-5p as circulating biomarkers for plaque instability. Singh S; de Ronde MWJ; Kok MGM; Beijk MA; De Winter RJ; van der Wal AC; Sondermeijer BM; Meijers JCM; Creemers EE; Pinto-Sietsma SJ Open Heart; 2020 Jun; 7(1):. PubMed ID: 32487772 [TBL] [Abstract][Full Text] [Related]
4. Circulating microRNAs as biomarkers for severe coronary artery disease. Zhang X; Cai H; Zhu M; Qian Y; Lin S; Li X Medicine (Baltimore); 2020 Apr; 99(17):e19971. PubMed ID: 32332683 [TBL] [Abstract][Full Text] [Related]
5. Alteration of circulating miRNAs during myocardial infarction and association with lipid levels. Ozuynuk-Ertugrul AS; Ekici B; Erkan AF; Coban N Lab Med; 2024 May; 55(3):361-372. PubMed ID: 38048807 [TBL] [Abstract][Full Text] [Related]
7. Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease-results from the large AtheroGene study. Karakas M; Schulte C; Appelbaum S; Ojeda F; Lackner KJ; Münzel T; Schnabel RB; Blankenberg S; Zeller T Eur Heart J; 2017 Feb; 38(7):516-523. PubMed ID: 27357355 [TBL] [Abstract][Full Text] [Related]
8. Circulating Extracellular miRNA Analysis in Patients with Stable CAD and Acute Coronary Syndromes. Zhelankin AV; Stonogina DA; Vasiliev SV; Babalyan KA; Sharova EI; Doludin YV; Shchekochikhin DY; Generozov EV; Akselrod AS Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209965 [TBL] [Abstract][Full Text] [Related]
9. Investigation of miR-26a-5p and miR-19a-3p expression levels in angiographically confirmed coronary artery disease. Coban N; Erkan AF; Ozuynuk-Ertugrul AS; Ekici B Acta Cardiol; 2023 Oct; 78(8):945-956. PubMed ID: 37376990 [TBL] [Abstract][Full Text] [Related]
10. Circulating microRNA expression profiling and bioinformatics analysis of patients with coronary artery disease by RNA sequencing. Zhong Z; Zhong W; Zhang Q; Zhang Q; Yu Z; Wu H J Clin Lab Anal; 2020 Jan; 34(1):e23020. PubMed ID: 31489700 [TBL] [Abstract][Full Text] [Related]
11. Clinical significance of circulating microRNAs as diagnostic biomarkers for coronary artery disease. Zhang L; Zhang Y; Xue S; Ding H; Wang Y; Qi H; Wang Y; Zhu W; Li P J Cell Mol Med; 2020 Jan; 24(1):1146-1150. PubMed ID: 31709737 [TBL] [Abstract][Full Text] [Related]
12. Circulating MicroRNAs as Novel Diagnostic Biomarkers for Very Early-onset (≤40 years) Coronary Artery Disease. DU Y; Yang SH; Li S; Cui CJ; Zhang Y; Zhu CG; Guo YL; Wu NQ; Gao Y; Sun J; Dong Q; Liu G; Li JJ Biomed Environ Sci; 2016 Aug; 29(8):545-554. PubMed ID: 27660218 [TBL] [Abstract][Full Text] [Related]
13. Circulatory miR-133b and miR-21 as Novel Biomarkers in Early Prediction and Diagnosis of Coronary Artery Disease. Kumar D; Narang R; Sreenivas V; Rastogi V; Bhatia J; Saluja D; Srivastava K Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32033332 [TBL] [Abstract][Full Text] [Related]
14. miR-941 as a promising biomarker for acute coronary syndrome. Bai R; Yang Q; Xi R; Li L; Shi D; Chen K BMC Cardiovasc Disord; 2017 Aug; 17(1):227. PubMed ID: 28830367 [TBL] [Abstract][Full Text] [Related]
15. Systematic review of microRNA biomarkers in acute coronary syndrome and stable coronary artery disease. Kaur A; Mackin ST; Schlosser K; Wong FL; Elharram M; Delles C; Stewart DJ; Dayan N; Landry T; Pilote L Cardiovasc Res; 2020 May; 116(6):1113-1124. PubMed ID: 31782762 [TBL] [Abstract][Full Text] [Related]
16. Circulating Exosomal miRNAs as Novel Biomarkers for Stable Coronary Artery Disease. Zhang P; Liang T; Chen Y; Wang X; Wu T; Xie Z; Luo J; Yu Y; Yu H Biomed Res Int; 2020; 2020():3593962. PubMed ID: 33381550 [TBL] [Abstract][Full Text] [Related]
18. Circulating miRNA-33: a potential biomarker in patients with coronary artery disease. Reddy LL; Shah SAV; Ponde CK; Rajani RM; Ashavaid TF Biomarkers; 2019 Feb; 24(1):36-42. PubMed ID: 30022694 [TBL] [Abstract][Full Text] [Related]
19. Plasma miR-22-5p, miR-132-5p, and miR-150-3p Are Associated with Acute Myocardial Infarction. Li H; Zhang P; Li F; Yuan G; Wang X; Zhang A; Li F Biomed Res Int; 2019; 2019():5012648. PubMed ID: 31179325 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the associations between circulating microRNAs and kidney function in coronary angiography patients. Muendlein A; Geiger K; Leiherer A; Saely CH; Fraunberger P; Drexel H Am J Physiol Renal Physiol; 2020 Feb; 318(2):F315-F321. PubMed ID: 31813253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]